Mark C. Schneyer, EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC (ACAD), sold 6,996 shares at $23.65 ($165K) on 2025-09-15, disclosed to the SEC on 2025-09-16.
Open-market sale of $165k ACAD by EVP, CHIEF FINANCIAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.65 | 3,498 | $83K | 50.0% |
| 2 | $23.65 | 3,498 | $83K | 50.0% |
| Total | $23.65 avg | 6,996 | $165K | 100% |
| Filing → |
| ACAD | SELL | 2026-04-07 | $60K | — | Filing → |
| ACAD | SELL | 2026-03-26 | $160K | — | Filing → |
| ACAD | SELL | 2025-11-19 | $486K | — | Filing → |